GSK Drug Achieves Functional Cure in 19-20% of Hepatitis B Patients
Two Phase 3 trials showed GSK's bepirovirsen produced functional cures in nearly one-fifth of chronic hepatitis B patients. Current nucleoside analogue treatments reach functional cures in only 1-3% of cases. The company has submitted the drug for regulatory approval.
StatAn experimental GSK medicine produced functional cures of chronic hepatitis B in 19% and 20% of patients across two late-stage trials, according to data released Thursday. The results far exceed the 1% to 3% functional cure rate seen with existing nucleoside analogue treatments. No patients on placebo reached functional cure in either study.
Some 250 million to 300 million people worldwide live with chronic hepatitis B. The infection can progress to cirrhosis and liver cancer and causes about 1 million deaths annually. The two Phase 3 trials tested bepirovirsen, referred to internally as "bepi." The medicine was given to adults with chronic hepatitis B infection.
GSK has submitted bepirovirsen for regulatory approval to the FDA and other agencies. The company described the outcomes in a statement accompanying the data release. Patients typically require lifelong treatment. Bepirovirsen works through a different mechanism that targets the viral RNA, offering the possibility of shorter treatment courses. The data were presented on May 28, 2026.
Key Facts
Potential Impact
- 01
Patients may gain access to a treatment with substantially higher cure rates if approved.
- 02
Health systems could see reduced long-term costs from fewer cirrhosis and liver cancer cases.
Transparency Panel
Related Stories
France 24Zambia’s Kabwe Residents Sue Mining Company Over Lead Contamination
Children in Kabwe, Zambia, show blood lead levels above World Health Organization limits after decades of mining. An estimated 140,000 women and children have joined a class-action lawsuit against Anglo American South Africa Limited.
citizen.co.zaEbola Outbreak in Eastern DRC Kills at Least 240 Since Early May
The virus has spread from Ituri province into other eastern DRC regions and Uganda. Health workers report reduced international aid and limited local resources as they attempt to contain transmission.
manilatimes.netOutbreaks of hantavirus and Ebola prompt U.S. quarantine and travel measures
The U.S. government ordered quarantines after a hantavirus outbreak on a cruise ship and imposed new traveler restrictions during an Ebola outbreak in Africa. Federal agencies stated that response operations continue despite recent staffing reductions at health agencies.